BET Inhibition Silences Expression of MYCN and BCL2 and Induces Cytotoxicity in Neuroblastoma Tumor ModelsAnastasia Wyce, Peter J. Tummino, Gopinath Ganji et al.|PLoS ONE|2013Cited by 205
Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762Aristeidis Chaidos, Anastasios Karadimitris, Binbin Liu et al.|Blood|2013Cited by 204
Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancerAnastasia Wyce, Olena Barbash, Yan Degenhardt et al.|Oncotarget|2013Cited by 179
Smyd3 regulates cancer cell phenotypes and catalyzes histone H4 lysine 5 methylationGlenn S. Van Aller, Ryan G. Kruger, Nicolas Reynoird et al.|Epigenetics|2012Cited by 174
Development and Validation of Reagents and Assays for EZH2 Peptide and Nucleosome High-Throughput ScreensElsie Diaz, Martín Brandt, Carl A. Machutta et al.|SLAS DISCOVERY|2012Cited by 60